Understanding cooperativity in human P450 mediated drug-drug interactions

被引:20
|
作者
Sligar, Stephen G.
Denisov, Ilia G.
机构
[1] Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Coll Med, Urbana, IL 61801 USA
[3] Univ Illinois, Ctr Biophys & Comp Biol, Urbana, IL 61801 USA
关键词
cytochrome P450; CYP3A4; homotropic cooperativity; heterotropic cooperativity; dose-response function;
D O I
10.1080/03602530701498521
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multiple drugs can interact, often leading to adverse side effects. One well documented site for these interactions includes the group of cytochrome P450 monoxygenases. Several human hepatic systems are known to bind more than a single substrate molecule which can give rise to the terms "homotropic and heterotopic cooperativity" to define the resultant thermodynamic and kinetic properties observed in drug metabolism in vestigations. We provide a means for understanding and quantitating these drug-drug interactions by documenting the functional properties of the various states of the enzyme and show that, even in the absence of true binding cooperativity, significant non-Michaelis metabolic profiles are possible.
引用
收藏
页码:567 / 579
页数:13
相关论文
共 50 条
  • [41] Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions
    Lee, Kye Sook
    Kim, Sang Kyum
    JOURNAL OF APPLIED TOXICOLOGY, 2013, 33 (02) : 100 - 108
  • [42] Drug Interactions of Thalidomide with Midazolam and Cyclosporine A: Heterotropic Cooperativity of Human Cytochrome P450 3A5
    Okada, Yusuke
    Murayama, Norie
    Yanagida, Chihiro
    Shimizu, Makiko
    Guengerich, F. Peter
    Yamazaki, Hiroshi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) : 18 - 23
  • [43] Characterization of the In Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Predictions of In Vivo Drug-Drug Interactions
    Kazmi, Faraz
    Sensenhauser, Carlo
    Greway, Tony
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (01) : 9 - 14
  • [44] Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes
    Kanayama, N.
    Kanari, C.
    Masuda, Y.
    Ohmori, S.
    Ooie, T.
    XENOBIOTICA, 2007, 37 (02) : 139 - 154
  • [45] Pharmacokinetic drug-drug interactions of JBPOS0101 mediated by cytochrome P450 3A4 and UDP-glucuronosyltransferases
    Hwang, Sejung
    Choi, Yong Moon
    Kim, Myoung-Seok
    Lee, SeungHwan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (07):
  • [46] Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions
    He, Rongjing
    Dai, Ziru
    Finel, Moshe
    Zhang, Feng
    Tu, Dongzhu
    Yang, Ling
    Ge, Guangbo
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (10) : 1254 - 1272
  • [47] PREDICTION OF DRUG-DRUG INTERACTIONS BASED ON CONTRIBUTION OF CYTOCHROME P450 ENZYME TO DRUG METABOLISM USING THE RAF APPROACH IN DRUG DISCOVERY
    Yokoo, Koji
    Tohda, Toshifumi
    Naritomi, Yoichi
    Ueda, Naoki
    Kadono, Keitaro
    Tabata, Kenji
    DRUG METABOLISM REVIEWS, 2015, 47 : 111 - 111
  • [48] Role of cytochrome P450 in drug interactions
    Zakia Bibi
    Nutrition & Metabolism, 5
  • [49] Integrated in vitro analysis for the in vivo prediction of cytochrome P450-mediated drug-drug interactions
    McGinnity, Dermot F.
    Waters, Nigel J.
    Tucker, James
    Riley, Robert J.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (06) : 1126 - 1134
  • [50] Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update
    Hemeryck, A
    Belpaire, FM
    CURRENT DRUG METABOLISM, 2002, 3 (01) : 13 - 37